Report Detail

Request for Sample of this report

Pharma & Healthcare Global Platinum based Cancer Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2974975
    • |
  • 18 February, 2019
    • |
  • Global
    • |
  • 119 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Scope of the Report:
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin in 2017 is about 71%, and the proportion is in decreasing trend from 2013 to 2017.
Asia-Pacific is the largest market, with a sales market share nearly 53% in 2017. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
The worldwide market for Platinum based Cancer Drug is expected to grow at a CAGR of roughly 4.3% over the next five years, will reach 1650 million US$ in 2024, from 1290 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Platinum based Cancer Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Cisplatin
Oxaliplatin
Carboplatin
Other

Market Segment by Applications, can be divided into
Colorectal Cancer
Ovarian Cancer
Lung Cancer 
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Platinum based Cancer Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Platinum based Cancer Drug, with price, sales, revenue and global market share of Platinum based Cancer Drug in 2017 and 2018.
Chapter 3, the Platinum based Cancer Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Platinum based Cancer Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Platinum based Cancer Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Platinum based Cancer Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Platinum based Cancer Drug Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Cisplatin
      • 1.2.2 Oxaliplatin
      • 1.2.3 Carboplatin
      • 1.2.4 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Colorectal Cancer
      • 1.3.2 Ovarian Cancer
      • 1.3.3 Lung Cancer
      • 1.3.4 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Sanofi
      • 2.1.1 Business Overview
      • 2.1.2 Platinum based Cancer Drug Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Sanofi Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Hengrui Medicine
      • 2.2.1 Business Overview
      • 2.2.2 Platinum based Cancer Drug Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 ASK Pharma
      • 2.3.1 Business Overview
      • 2.3.2 Platinum based Cancer Drug Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 ASK Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Yi Bai Pharmaceutical
      • 2.4.1 Business Overview
      • 2.4.2 Platinum based Cancer Drug Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Qilu Pharmaceutical
      • 2.5.1 Business Overview
      • 2.5.2 Platinum based Cancer Drug Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Teva
      • 2.6.1 Business Overview
      • 2.6.2 Platinum based Cancer Drug Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Teva Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Pfizer
      • 2.7.1 Business Overview
      • 2.7.2 Platinum based Cancer Drug Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Pfizer Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Dr Reddy's Laboratories
      • 2.8.1 Business Overview
      • 2.8.2 Platinum based Cancer Drug Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Mylan
      • 2.9.1 Business Overview
      • 2.9.2 Platinum based Cancer Drug Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Mylan Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Sun Pharma
      • 2.10.1 Business Overview
      • 2.10.2 Platinum based Cancer Drug Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Sun Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Novartis
      • 2.11.1 Business Overview
      • 2.11.2 Platinum based Cancer Drug Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Novartis Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Debiopharm
      • 2.12.1 Business Overview
      • 2.12.2 Platinum based Cancer Drug Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Debiopharm Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Accord Healthcare
      • 2.13.1 Business Overview
      • 2.13.2 Platinum based Cancer Drug Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 SK Chemicals
      • 2.14.1 Business Overview
      • 2.14.2 Platinum based Cancer Drug Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 SK Chemicals Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Platinum based Cancer Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Platinum based Cancer Drug Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Platinum based Cancer Drug Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Platinum based Cancer Drug Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Platinum based Cancer Drug Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Platinum based Cancer Drug Market Analysis by Regions

    • 4.1 Global Platinum based Cancer Drug Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Platinum based Cancer Drug Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Platinum based Cancer Drug Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 4.3 Europe Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 4.5 South America Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Platinum based Cancer Drug Sales and Growth Rate (2014-2019)

    5 North America Platinum based Cancer Drug by Country

    • 5.1 North America Platinum based Cancer Drug Sales, Revenue and Market Share by Country
      • 5.1.1 North America Platinum based Cancer Drug Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Platinum based Cancer Drug Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 5.3 Canada Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Platinum based Cancer Drug Sales and Growth Rate (2014-2019)

    6 Europe Platinum based Cancer Drug by Country

    • 6.1 Europe Platinum based Cancer Drug Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Platinum based Cancer Drug Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Platinum based Cancer Drug Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 6.3 UK Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 6.4 France Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 6.5 Russia Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 6.6 Italy Platinum based Cancer Drug Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Platinum based Cancer Drug by Country

    • 7.1 Asia-Pacific Platinum based Cancer Drug Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Platinum based Cancer Drug Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Platinum based Cancer Drug Revenue and Market Share by Country (2014-2019)
    • 7.2 China Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 7.3 Japan Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 7.4 Korea Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 7.5 India Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Platinum based Cancer Drug Sales and Growth Rate (2014-2019)

    8 South America Platinum based Cancer Drug by Country

    • 8.1 South America Platinum based Cancer Drug Sales, Revenue and Market Share by Country
      • 8.1.1 South America Platinum based Cancer Drug Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Platinum based Cancer Drug Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Platinum based Cancer Drug Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Platinum based Cancer Drug by Countries

    • 9.1 Middle East and Africa Platinum based Cancer Drug Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Platinum based Cancer Drug Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Platinum based Cancer Drug Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Platinum based Cancer Drug Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Platinum based Cancer Drug Sales and Growth Rate (2014-2019)

    10 Global Platinum based Cancer Drug Market Segment by Type

    • 10.1 Global Platinum based Cancer Drug Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Platinum based Cancer Drug Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Platinum based Cancer Drug Revenue and Market Share by Type (2014-2019)
    • 10.2 Cisplatin Sales Growth and Price
      • 10.2.1 Global Cisplatin Sales Growth (2014-2019)
      • 10.2.2 Global Cisplatin Price (2014-2019)
    • 10.3 Oxaliplatin Sales Growth and Price
      • 10.3.1 Global Oxaliplatin Sales Growth (2014-2019)
      • 10.3.2 Global Oxaliplatin Price (2014-2019)
    • 10.4 Carboplatin Sales Growth and Price
      • 10.4.1 Global Carboplatin Sales Growth (2014-2019)
      • 10.4.2 Global Carboplatin Price (2014-2019)
    • 10.5 Other Sales Growth and Price
      • 10.5.1 Global Other Sales Growth (2014-2019)
      • 10.5.2 Global Other Price (2014-2019)

    11 Global Platinum based Cancer Drug Market Segment by Application

    • 11.1 Global Platinum based Cancer Drug Sales Market Share by Application (2014-2019)
    • 11.2 Colorectal Cancer Sales Growth (2014-2019)
    • 11.3 Ovarian Cancer Sales Growth (2014-2019)
    • 11.4 Lung Cancer Sales Growth (2014-2019)
    • 11.5 Other Sales Growth (2014-2019)

    12 Platinum based Cancer Drug Market Forecast (2019-2024)

    • 12.1 Global Platinum based Cancer Drug Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Platinum based Cancer Drug Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Platinum based Cancer Drug Market Forecast (2019-2024)
      • 12.2.2 Europe Platinum based Cancer Drug Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Platinum based Cancer Drug Market Forecast (2019-2024)
      • 12.2.4 South America Platinum based Cancer Drug Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Platinum based Cancer Drug Market Forecast (2019-2024)
    • 12.3 Platinum based Cancer Drug Market Forecast by Type (2019-2024)
      • 12.3.1 Global Platinum based Cancer Drug Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Platinum based Cancer Drug Market Share Forecast by Type (2019-2024)
    • 12.4 Platinum based Cancer Drug Market Forecast by Application (2019-2024)
      • 12.4.1 Global Platinum based Cancer Drug Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Platinum based Cancer Drug Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Platinum based Cancer Drug . Industry analysis & Market Report on Platinum based Cancer Drug is a syndicated market report, published as Global Platinum based Cancer Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Platinum based Cancer Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,784.00
      		4,176.00
      		5,568.00
      		3,250.32
      		4,875.48
      		6,500.64
      		549,631.20
      		824,446.80
      		1,099,262.40
      		290,336.40
      		435,504.60
      		580,672.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo